Neuroone Medical Technologies is trading 5% up at $2.29, extending its recent rally amid healthcare-sector strength despite broader U.S. indexes trading lower on August 20, 2026.
- No new company-specific announcement was identified on August 20.
- The latest fundamental catalyst was the August 13 fiscal third-quarter update, reporting 16% revenue growth and 59.9% gross margins.
- The move is best attributed to healthcare-sector strength and investor rotation.